Loss of p53 in triple-negative breast cancer may activate ATF6 processing (69), and dormant squamous carcinoma cells leverage ATF6 to maintain survival in vitro and in vivo (112). The gene discussed is ATF6; the disease is triple-negative breast carcinoma.